Therapeutic strategies for inhibition of interleukin-6 mediated multiple myeloma cell growth

Leukemia Research

Volumn 20, Issue 4, 1996, Pages 303-307

  Ogata, A ^a   Anderson, K C ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR;

CELL GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; MULTIPLE MYELOMA; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0029994074     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/0145-2126(95)00085-2     Document Type: Note

References (60)

1. S. Akira T. Taga T. Kishimoto Interleukin-6 in biology and medicine Adv. Immunol. 54 1993 1
2. Lust J. A., Donovan K. A., Kline M. P., Greipp P. R., Kyle R. A., & Maihle N. J. Isolation of an mRNA encoding a soluble form of the human interleukin-6 receptor. Cytokine 4 , 96.
3. M. Honda S. Yamamoto M. Cheng K. Yasukawa H. Suzuki T. Saito Y. Osugi T. Tokunaga T. Kishimoto Human soluble IL-6 receptor: its detection and enhanced release by HIV infection J. Immunol. 148 1992 2175
4. X.-G. Zhang J.-J. Gu Z.-Y. Lu K. Yasukawa G.D. Yancopoulos K. Turner M. Shoyab T. Taga T. Kishimoto R. Bataille B. Klein Ciliary neurotrophic factor, interleukin-11, leukemia inhibitory factor, and oncostatin M are growth factors for human myeloma cell lines using the interleukin-6 signal transducer GP130 J. Exp. Med. 177 1994 1337
5. N. Nishimoto A. Ogata Y. Shima T. Tani H. Ogawa M. Nakagawa H. Sugiyama K. Yoshizaki T. Kishimoto Oncostatin M, leukemia inhibitory factor, and interleukin-6 induce the proliferation of human plasmacytoma cells via the common signal transducer, GP130 J. Exp. Med. 179 1994 1343
6. S. Suematsu T. Matsusaka T. Matsuda S. Ohno J. Miyazaki K. Yamamura T. Hirano T. Kishimoto Generation of plasmacytomas with the chromosomal translocation t(12;15) in interleukin-6 transgenic mice 2nd Edn Proc. natn. Acad. Sci. USA 89 1994 232
7. M. Diamant M.B. Hansen K. Rieneck M. Svenson K. Yasukawa K. Bendtzen Differential interleukin-6 (IL-6) responses of three established myeloma cell lines in the presence of soluble human IL-6 receptors Leukemia Res. 20 6 1996 291
8. B. Klein X.G. Zhang L.Z. Yang R. Bataille Interleukin-6 in human multiple myeloma Blood 85 1995 1198
9. D. Chauhan H. Uchiyama M. Urashima K. Yamamoto K.C. Anderson Regulation of interleukin-6 in multiple myeloma and bone marrow stromal cells Stem Cells 13 1995 35
10. M. Kawano T. Hirano T. Matsuda T. Taga Y. Horii K. Iwato H. Asaoku B. Tang O. Tanabe H. Tanaka A. Kuramoto T. Kishimoto Autocrine generation and requirement of BSF2/IL-6 for human multiple myeloma Nature 332 1988 83
11. K.C. Anderson R.C. Jones C. Morimoto P. Leavitt B. Barut Response of purified myeloma cells to hematopoietic growth factors Blood 73 1989 1915
12. H. Hata H. Xiao M.T. Petrucci J. Woodliff R. Chang J. Epstein Interleukin-6 gene expression in multiple myeloma: a characteristic of immature tumor cells Blood 81 1993 3357
13. B. Barut L.I. Zon M.K. Cochran S.R. Paul D. Chauhan A. Mohrbacher J. Fingeroth K.C. Anderson Role of interleukin 6 in the growth of myeloma-derived cell lines Leukemia Res. 16 1992 951
14. J. Hitzler H. Martinez-Valdez D. Bergsagel M.D. Minden Role of interleukin-6 in the proliferation of human multiple myeloma cell lines OCI-MY1-7 established from patients with advanced stage of the disease Blood 78 1991 1996
15. M. Schwab A.T. Brini M.C. Bosco F. Rubboli M. Egawa J. Zhao G.L. Princler H. Kung Disruption by interferon-α of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of IL-6 receptor α- and β-chains J. Clin. Invest. 94 1994 2317
16. Y. Levy A. Tsapis J.C. Brouet Interleukin-6 antisense oligonucleotides inhibit the growth of human myeloma cell lines J. Clin. Invest. 88 1991 696
17. J.J. Westendorf G.J. Ahmann R.J. Armitage M.K. Spriggs J.A. Lust P.R. Greipp J.A. Katzmann D.F. Jelinek CD40 expression on malignant plasma cells: role in stimulation of autocrine IL-6 secretion by a human myeloma cell line J. Immunol. 152 1994 117
18. M. Urashima D. Chauhan H. Uchiyama G. Freeman K.C. Anderson CD40 ligand triggered interleukin-6 secretion in multiple myeloma Blood 85 1995 1903
19. D.M. Hilbert M.-Y. Shen U.R. Rapp S. Rudikoff T cells induce terminal differentiation of transformed B cells to mature plasma cell tumors 2nd Edn Proc. natn. Acad. Sci. USA 92 1995 649
20. M. Kawano H. Tanaka H. Ishikawa M. Nobuyoshi K. Iwato H. Asaoku O. Tanabe A. Kuramoto Interleukin-1 accelerates autocrine growth of myeloma cells through interleukin-6 in human myeloma Blood 73 1989 2145
21. X.G. Zhang R. Bataille M. Jourdan S. Saeland J. Banchereau P. Mannoni B. Klein Granulocyte-macrophage colony-stimulating factor synergizes with interleukin-6 in supporting the proliferation of human myeloma cells Blood 76 1990 2599
22. X.G. Zhang C. Rodriguez J. Widjenes Z.J. Gu B. Morel-Fournier J.L. Harrouseau R. Bataille J.F. Rossi B. Klein Interleukin-10 is a proliferation factor but not a differentiation factor for human myeloma cells Blood 85 1995 2521
23. B. Barut D. Chauhan H. Uchiyama K.C. Anderson Interleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro J Clin Invest. 92 1993 1993
24. B. Klein X.-G. Zhang M. Jourdan J. Content F. Houssiau L. Aarden M. Piechaczyk R. Bataille Paracrine rather than autocrine regulation of myelomacell growth and differentiation by interleukin-6 Blood 73 1989 512
25. A. Lichtenstein J. Berenson D. Norman M.P. Chang A. Carlile Production of cytokines by bone marrow cells obtained from patients with multiple myeloma Blood 74 1989 1266
26. F. Caligaris-Cappio L. Bergui M.G. Gregoretti G. Gaidano M. Gaboli M. Schena A. Zallone C. Marchisio Role of bone marrow stromal cells in the growth of human multiple myeloma Blood 77 1991 2688
27. X.G. Zhang J.P. Gaillard N. Robillard A.Y. Lu Z.J. Gu M. Jourdan J.M. Boiron R. Bataille B. Klein Reproducible obtaining of human myeloma cell lines as a model for tumor stem cell study in human multiple myeloma Blood 83 1994 3654
28. H. Uchiyama B.A. Barut D. Chauhan S.A. Cannistra K.C. Anderson Characterization of adhesion molecules on human myeloma cells Blood 80 1992 2306
29. E.J.M. Ahsmann H.M. Lokhorst A.W. Dekker A.C. Bloem Lymphocyte function-associated antigen-1 expression on plasma cells correlates with tumor growth in multiple myeloma Blood 79 1992 2068
30. H. Uchiyama B.A. Barut A.F. Mohrbacher D. Chauhan K.C. Anderson Adhesion of human myeloma-derived cell lines to bone marrow stromal cells stimulates interleukin-6 secretion Blood 82 1993 3712
31. H.M. Lokhorst T. Lamme M. deSmet S. Klein R.A. de Weger R. van Oers A.C. Bloem Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures Blood 84 1994 2269
32. I. Kim H. Uchiyama D. Chauhan K.C. Anderson Cell surface expression and functional significance of adhesion molecules on human myeloma-derived cell lines Br. J. Hematol. 87 1994 483
33. Barille S., Collette M., Bataille R. & Amiot M. Myeloma cells upregulate IL-6 but downregulate osteocalcin production by osteoblastic cells through cell-cell-contact. Blood (In press).
34. Chauhan D., Uchiyama H., Akbarali Y., Urashima M., Yamamoto K. I., Libermann T. A., Anderson K. C. Multiple myeloma cell adhesion-induced interleukin-6 expression in bone marrow stromal cells involves activation of NF-kB Blood (In press).
35. M. Kawano N. Huang Y. Harada A. Sakai H. Tanaka K. Iwato A. Kuramoto Identification of immature and mature myeloma cells in the bone marrow of human myelomas Blood 82 1993 564
36. M. Kawano K. Mihara N. Huang T. Tsujimoto A. Kuramoto Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis Blood 85 1995 487
37. R. Bataille M. Jourdan X.-G. Zhang B. Klein Serum levels of interleukin-6, a potent myeloma cell growth factor, as a reflect of disease severity of plasma cell dyscrasias J. Clin. Invest. 84 1989 2008
38. J.B.G. Bell A. Montes R. Gooding P. Riches D. Cunningham B.C. Millar Comparison of interleukin-6 levels in the bone marrow of multiple myeloma patients with disease severity and clonogenicity in vitro Leukemia 5 1991 958
39. H. Ludwig D.M. Nachbaur E. Fritz M. Krainer H. Huber Interleukin-6 is a prognostic factor in multiple myeloma Blood 77 1991 2794
40. E. Solary M. Guiguet V. Zeller R.-O. Casanovas D. Caillot P. Chavant H. Guy G. Mack Radioimmunoassay for the measurement of serum IL-6 and its correlation with tumour cell mass parameters in multiple myeloma Am. J. Hematol. 39 1992 163
41. O.F. Ballester L.C. Moscinski G.H. Lyman J.V. Chancy H.I. Saba A.S.D. Spiers C. Klein High levels of interleukin-6 are associated with low tumor burden and low growth fraction in multiple myeloma Blood 83 1994 1903
42. T.-T. Pelliniemi K. Irjala K. Mattila K. Pulkki A. Rajamäki A. Tienhaara M. Laakso R. Lahtinen Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma Blood 85 1995 765
43. R. Bataille M. Boccadoro B. Klein B. Durie A. Pileri C-reactive protein and B-2 microglobulin produce a simple and powerful myeloma staging system Blood 80 1992 733
44. P.R. Griepp J.P. Gaillard L.A. Kalish M.M. Oken A.M. Miller R.A. Kyle B. Klein Independent prognostic value for serum soluble interleukin-6 receptor (sIL-6R) in Eastern Cooperative Oncology Group (ECOG) myeloma trial E9487 2nd Edn Proc. Am. Soc. Clin. Oncol. 12 1993 404
45. J.-P. Gaillard R. Bataille H. Brailly C. Zuber K. Yasukawa M. Attal N. Maruo T. Taga T. Kishimoto B. Klein Increased and highly stable levels of functional soluble interleukin-6 receptor in sera of patients with monoclonal gammopathy Eur. J. Immunol. 23 1993 820
46. R.D. Brown B. Gorenc J. Gibson D. Joshua Interleukin-6 receptor expression and saturation on bone marrow cells of patients with multiple myeloma Leukemia 7 1992 221
47. B. Klein J. Wijdenes X.-G. Zhang M. Jourdan J.-M. Boiron J. Brochier J. Liautard M. Merlin C. Clement B. Morel-Fournier Z.-Y. Lu P. Mannoni J. Sany R. Bataille Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia Blood 78 1991 1198
48. H. Jernberg-Wiklund M. Pettersson K. Nilsson Recombinant interferon-γ inhibits the growth of IL-6-dependent human multiple myeloma cell lines in vitro Eur. J. Haematol. 46 1991 231
49. M. Portier X.-G. Zhang E. Caron Z.-Y. Lu R. Bataille B. Klein γ-Interferon in multiple myeloma: inhibition of interleukin-6 (IL-6)-dependent myeloma cell growth and downregulation of IL-6-receptor expression in vitro Blood 81 1993 3076
50. A. Ogata N. Nishimoto Y. Shima K. Yoshizaki T. Kishimoto Inhibitory effect of all- trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction Blood 84 1994 3040
51. H. Ishikawa H. Tanaka K. Iwato O. Tanabe H. Asaoku M. Nobuyoshi I. Yamamoto M. Kawano A. Kuramoto Effect of glucocorticoids on the biologic activities of plasma cells: inhibition of Interleukin-1β osteoclast activating factor-induced bone resorption Blood 75 1990 715
52. J. Hardin S. MacLeod I. Grigorieva R. Chang B. Barlogie H. Xiao J. Epstein Interleukin-6 prevents dexamethasone-induced myeloma cell death Blood 84 1994 3063
53. F. Herrmann M. Andreff H.J. Gruss M.A. Brach M. Lubbert R. Mertelsmann Interleukin-4 inhibits growth of multiple myeloma by suppressing interleukin-6 expression Blood 78 1991 2070
54. C. Taylor T.M. Grogan S.E. Salmon Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms Blood 75 1990 1114
55. H. Suzuki K. Yasukawa T. Saito R. Goitsuka A. Hasegawa Y. Ohsugi T. Taga T. Kishimoto Anti-human interleukin-6 receptor antibody inhibits human myeloma growth in vivo Eur. J. Immunol. 22 1992 1989
56. K. Sato M. Tsuciya J. Saldanha Y. Koshihara Y. Ohsugi T. Kishimoto M.M. Bendig Reshaping a human antibody to inhibit interleukin-6 dependent tumor cell growth Cancer Res. 53 1993 851
57. R.J. Kreitman C.B. Siegall D.J.P. Fitzgerald J. Epstein B. Barlogie I. Pastan Interleukin-6 fused to mutant form of Pseudomonas exotoxin kills malignant cells from patients with multiple myeloma Blood 79 1992 1775
58. D.E. Chadwick N. Jamal H.A. Messner J.R. Murphy M.D. Minden Differential sensitivity of human myeloma cell lines and bone marrow colony forming cells to a recombinant diphtheria toxin-interleukin-6 fusion protein Br. J. Haematol. 85 1993 25
59. E.T. Keller W.B. Ershler Effect of IL-6 receptor antisense oligodeoxynucleotide on in vitro proliferation of myeloma cells J. Immunol. 154 1995 4091
60. F.M. Uckun W.E. Evans C.J. Forsyth K.G. Waddick L.T. Ahlgren L.M. Chelstrom A. Burkhardt J. Bolen D.E. Myers Biotherapy of B-cell precursor leukemia by targeting genistein to CD19-associated tyrosine kinases Science 267 1995 886